Related Experiment Video
Updated: Jul 19, 2026

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
Published on: July 3, 2013
Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis
Megan Cully1, Han You, Arnold J Levine
1The Campbell Family Institute for Breast Cancer Research, University Health Network, University of Toronto, Toronto, Ontario M5G 2C1, Canada.
Abstract:
The tumour-suppressor phosphatase with tensin homology (PTEN) is the most important negative regulator of the cell-survival signalling pathway initiated by phosphatidylinositol 3-kinase (PI3K). Although PTEN is mutated or deleted in many tumours, deregulation of the PI3K-PTEN network also occurs through other mechanisms. Crosstalk between the PI3K pathways and other tumorigenic signalling pathways, such as those that involve Ras, p53, TOR (target of rapamycin) or DJ1, can contribute to this deregulation. How does the PI3K pathway integrate signals from numerous sources, and how can this information be used in the rational design of cancer therapies?
Insights
Phosphatase with tensin homology (PTEN) regulates cell survival by inhibiting the phosphatidylinositol 3-kinase (PI3K) pathway. Deregulation of this critical network, through mutations or crosstalk with other pathways, contributes to cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- The tumor suppressor phosphatase with tensin homology (PTEN) is a key negative regulator of the phosphatidylinositol 3-kinase (PI3K) pathway.
- While PTEN mutations are common in cancer, PI3K-PTEN network deregulation also occurs via other mechanisms.
- Crosstalk between PI3K and other oncogenic pathways (e.g., Ras, p53, TOR, DJ1) contributes to tumor development.
Purpose of the Study:
- To elucidate how the PI3K pathway integrates signals from diverse sources.
- To explore the therapeutic potential of targeting the PI3K pathway in cancer treatment.
Main Methods:
- This study involves a review and analysis of existing research on the PI3K-PTEN signaling network.
- Focus on understanding signal integration and crosstalk mechanisms.
Main Results:
- The PI3K pathway is a central hub integrating signals from multiple oncogenic pathways.
- PTEN loss or inactivation is a critical event leading to uncontrolled cell survival and proliferation.
- Interactions with Ras, p53, TOR, and DJ1 pathways highlight the complexity of PI3K network deregulation.
Conclusions:
- Understanding PI3K pathway signal integration is crucial for cancer research.
- Targeting the PI3K pathway and its regulators offers a promising strategy for rational cancer therapy design.
Related Concept Videos
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

